We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
+$362M
Cap. Flow
-$348M
Cap. Flow %
-25.31%
Top 10 Hldgs %
62.01%
Holding
142
New
43
Increased
15
Reduced
9
Closed
60

Top Buys

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$53.1M
2
KSU
Kansas City Southern
KSU
+$31.9M
3
PF
Pinnacle Foods, Inc.
PF
+$27.7M
4
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$5.3M
5
PCRX icon
Pacira BioSciences
PCRX
+$3.43M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$12.3M
2
INSM icon
Insmed
INSM
+$7.51M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$6.36M
4
DYNC
Vistra Energy Corp.
DYNC
+$5.07M
5
NXH
Neighborhood Intelligence Inc
NXH
+$3.25M

Sector Composition

Rank Sector Weight
1 Miscellaneous 89.94%
2 Technology 3.93%
3 Industrials 2.49%
4 Consumer Staples 2.13%
5 Healthcare 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
26
Pacira BioSciences
PCRX
$1.03B
$3.95M 0.29%
+86,500
New +$3.43M
OTIC
27
DELISTED
Otonomy, Inc.
OTIC
$2.83M 0.21%
510,000
+267,400
+110% +$1.16M
EGOV
28
CALL
DELISTED
NIC Inc
EGOV
$2.42M 0.18%
+146,100
New +$2.47M
NL icon
29
NLI Holdings
NL
$329M
$1.98M 0.14%
+139,255
New +$1.77M
IMMR icon
30
CALL
Immersion
IMMR
$254M
$1.97M 0.14%
+279,400
New +$2.02M
PCRX icon
31
PUT
Pacira BioSciences
PCRX
$1.03B
$1.22M 0.09%
+26,800
New +$1.06M
CAA
32
DELISTED
CalAtlantic Group, Inc.
CAA
$992K 0.07%
+17,600
New +$860K
LPCN icon
33
PUT
Lipocine
LPCN
$17.9M
$959K 0.07%
16,406
-7,712
-32% -$480K
IXYS
34
DELISTED
IXYS Corp
IXYS
$958K 0.07%
40,000
+23,000
+135% +$555K
STRP
35
DELISTED
Straight Path Communications Inc.
STRP
$880K 0.06%
4,840
+340
+8% +$61.7K
SNI
36
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$854K 0.06%
10,000
+1,000
+11% +$82.6K
TEVA icon
37
CALL
Teva Pharmaceuticals
TEVA
$42.5B
$819K 0.06%
43,200
+21,600
+100% +$325K
TRCO
38
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$747K 0.05%
17,600
+3,100
+21% +$128K
INFY icon
39
Infosys
INFY
$48.8B
$702K 0.05%
+86,500
New +$658K
AET
40
DELISTED
Aetna Inc
AET
$631K 0.05%
+3,500
New +$601K
AAAP
41
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$612K 0.04%
+7,500
New +$582K
COL
42
DELISTED
Rockwell Collins
COL
$475K 0.03%
+3,500
New +$469K
DYN
43
PUT
DELISTED
Dynegy, Inc.
DYN
$457K 0.03%
38,500
– –
HSNI
44
DELISTED
HSN, Inc.
HSNI
$426K 0.03%
+10,560
New +$418K
CAVM
45
DELISTED
Cavium, Inc.
CAVM
$419K 0.03%
+5,000
New +$387K
LPCN icon
46
Lipocine
LPCN
$17.9M
$409K 0.03%
7,000
-16,606
-70% -$1.03M
MON
47
DELISTED
Monsanto Co
MON
$409K 0.03%
+3,500
New +$416K
GNCMA
48
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$390K 0.03%
10,000
+2,500
+33% +$102K
CPN
49
DELISTED
Calpine Corporation
CPN
$378K 0.03%
+25,000
New +$375K
CCC
50
DELISTED
Calgon Carbon Corp
CCC
$375K 0.03%
+17,600
New +$378K
1
2
3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return

DLD Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, DLD Asset Management held 142 positions worth $1.38B, up 36% from $1.02B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

DLD Asset Management withdrew a net $348M in Q4 2017, closing 60 positions and reducing 9 holdings. Its most notable exit was PTC Therapeutics, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 95% a quarter earlier, followed by Technology and Industrials.

Against the trend, DLD Asset Management opened a new position in Cognizant worth $51.6M.

  • DLD Asset Management's largest Q4 2017 buy was Cognizant: 726,740 shares worth $51.6M.
  • DLD Asset Management added most to Otonomy, Inc. in Q4 2017, an estimated $1.16M increase.
  • DLD Asset Management's biggest Q4 2017 reduction was Lipocine, cutting an estimated $1.03M.
  • DLD Asset Management fully exited PTC Therapeutics in Q4 2017, selling an estimated $12.3M.
  • DLD Asset Management's ten largest holdings make up 62% of its $1.38B portfolio in Q4 2017.
  • DLD Asset Management opened 43 new positions and closed 60 in Q4 2017.
  • DLD Asset Management's portfolio value rose 36% quarter-over-quarter to $1.38B.

Based on DLD Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.